Results 41 to 50 of about 1,067,778 (171)

Evaluating the Impact of Beta-Lactam Allergy Labels on Patient Outcomes in Bone Marrow Transplant Patients

open access: yes
Background: Patients with a beta-lactam allergy noted in their medical record (i.e., allergy label) receive different antibiotics, even when an allergy is not truly present.
Haxby, Benjamin M.
core   +6 more sources

Beta-lactam allergy in patients: an antibiotic stewardship challenge. [PDF]

open access: yesEur J Hosp Pharm, 2022
Patients are commonly reported as being allergic to beta-lactam (BL) antibiotics. However, many patients with this reported allergy are able to receive BL treatments because they do not have true allergies. In many cases these are simply intolerances due to side effects reported as an allergy.
Bodega-Azuara J   +7 more
europepmc   +4 more sources

Meropenem allergy testing performed at the bedside of hospitalized patients labelled with a penicillin allergy

open access: yesAllergology International, 2023
Background: Meropenem is a widely prescribed beta-lactam for hospitalized patients. There are few data on meropenem allergy assessments in inpatients with a reported history of penicillin allergy who require a treatment with meropenem.
Laura Marín   +7 more
doaj   +1 more source

Allergic Reactions and Cross-Reactivity Potential with Beta-Lactamase Inhibitors

open access: yesPharmacy, 2019
Although beta-lactam allergies are an emerging focus of stewardship programs and interventions, less is publicly released regarding allergies to beta-lactamase inhibitors. This review presents and evaluates the data regarding allergic reactions with beta-
Kayla R. Stover   +2 more
doaj   +1 more source

Drug Allergy in children: focus on beta-lactams and NSAIDs.

open access: yesActa bio-medica : Atenei Parmensis, 2020
Drug hypersensitivity reactions (DHRs) are adverse reactions to a drug. In children, most common drugs inducing such reactions include beta-lactams (BLs) and non-steroidal anti-inflammatory drugs (NSAIDs). The aim of the present work was to provide current knowledge on the management of DHRs in the pediatric population, focusing on BLs and NSAIDs ...
Cravidi C.   +12 more
openaire   +4 more sources

Use of electronic medical records to describe the prevalence of allergic diseases in Canada

open access: yesAllergy, Asthma & Clinical Immunology, 2021
Background Leveraging the data management resources of the Canadian Primary Care Sentinel Surveillance Network (CPCSSN) is a viable approach for describing the prevalence of allergic disease documented in primary care settings.
Alexander G. Singer   +5 more
doaj   +1 more source

De-Labeling Beta-Lactam Allergies in Haematology/Oncology Patients: ORAL (Oncology Removing Allergy Labels) [PDF]

open access: yes, 2023
Pharmacy residents have the opportunity to complete a research project during their residency training, which provides them with skills on how to conduct and manage a research project.
Koo, Alicia   +6 more
core   +1 more source

Management and Implications of Beta-Lactam Allergies

open access: yesCureus
Beta-lactam antibiotics are essential components in the current antimicrobial treatment strategy, playing a crucial role in ambulatory patients and hospitalized patients. Despite their prominent therapeutic index, the use of beta-lactam can lead to adverse effects, with allergic reactions being the most concerning because of their severity ...
Zavaleta-Monestel, Esteban   +4 more
openaire   +2 more sources

A Retrospective Cross-sectional Study Evaluating Beta-lactam Allergy Labeling in Hospitalized Patients [PDF]

open access: yes, 2018
Pharmacy residents have the opportunity to complete a research project during their residency training, which provides them with skills on how to conduct and manage a research project.
Graham, Christopher   +2 more
core   +1 more source

Evaluating a virtual paediatric adverse drug reaction clinic

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy